3SBio (TRSBF) Price-to-Tangible-Book : 1.68 (As of May. 01, 2024)

View and export this data going back to 2018. Start your Free Trial

What is 3SBio Price-to-Tangible-Book?

As of today (2024-05-01), 3SBio's share price is $0.80. 3SBio's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $0.48. Hence, 3SBio's Price to Tangible Book Ratio of today is 1.68.

The historical rank and industry rank for 3SBio's Price-to-Tangible-Book or its related term are showing as below:

TRSBF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.7 Med: 4.99 Max: 157.29
Current: 1.7

During the past 10 years, 3SBio's highest Price to Tangible Book Ratio was 157.29. The lowest was 1.70. And the median was 4.99.

TRSBF's Price-to-Tangible-Book is ranked better than
68.8% of 1221 companies
in the Biotechnology industry
Industry Median: 2.69 vs TRSBF: 1.70

A closely related ratio is called PB Ratio. As of today, 3SBio's share price is $0.80. 3SBio's Book Value per Sharefor the quarter that ended in Dec. 2023 was $0.81. Hence, 3SBio's P/B Ratio of today is 0.99.

3SBio Price-to-Tangible-Book Historical Data

The historical data trend for 3SBio's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3SBio Price-to-Tangible-Book Chart

3SBio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

7.69

4.88

1.97

1.89

1.68

3SBio Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															1.97	2.12	1.89	1.82	1.68

Competitive Comparison of 3SBio's Price-to-Tangible-Book

For the Biotechnology subindustry, 3SBio's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3SBio's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3SBio's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where 3SBio's Price-to-Tangible-Book falls into.

3SBio Price-to-Tangible-Book Calculation

3SBio's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.80	/	0.475
	=	1.68

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

3SBio Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of 3SBio's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

3SBio (TRSBF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio Inc (OTCPK:TRSBF) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

01530:Hong Kong 83B:Germany

Address

No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN, 110027

Website

https://www.3sbio.com

3SBio Inc, or 3SBio, is one of the largest and most established biotech drugmakers in China. In 2021, it reported revenue of CNY 6.3 billion. Approximately 90% of its revenue is derived from four core drugs: TPIAO (rhTPO), Yisaipu (biosimilar of etanercept, a TNF-alpha inhibitor), rhEPO, and Mandi (minoxidil). With the exception of minoxidil, an over-the-counter drug, the others are all older generation biologics. Most of the pipeline candidates are "me-too" drugs and in general are still at an early stage.

3SBio (TRSBF) Headlines

No Headlines